Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current scenario of pyrazole hybrids with in vivo therapeutic potential against cancers
Zhi Xu, Yafei Zhuang, Qingtai Chen
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115495-115495
Closed Access | Times Cited: 25

Showing 25 citing articles:

The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies
George Mihai Niţulescu, Gheorghe Stancov, Oana Cristina Șeremet, et al.
Molecules (2023) Vol. 28, Iss. 14, pp. 5359-5359
Open Access | Times Cited: 28
New molecular hybrids integrated with quinoxaline and pyrazole structural motifs: VGFR2 inhibitors and apoptosis inducers
Magda M. F. Ismail, Taghreed Z. Shawer, Rabab S. Ibrahim, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108182-108182
Closed Access
Enhanced Anticancer Selectivity of Cyclometalated Imidazole/Pyrazole-Imine IridiumIII Complexes Through the Switch from Cationic to Zwitterionic Forms
Zhe Liu, Kangning Lai, Pengwei Li, et al.
Inorganic Chemistry (2025)
Closed Access
Pyrazole: an Emerging Privileged Scaffold in Drug Discovery
Mohammad A. Alam
Future Medicinal Chemistry (2023) Vol. 15, Iss. 21, pp. 2011-2023
Open Access | Times Cited: 17
Design, synthesis and potent anti-pancreatic cancer activity of new pyrazole derivatives bearing chalcone, thiazole and thiadiazole moieties: gene expression, DNA fragmentation, cell cycle arrest and SAR
Monica G. Kamel, Farid M. Sroor, Mahmoud Kh. Hanafy, et al.
RSC Advances (2024) Vol. 14, Iss. 37, pp. 26954-26970
Open Access | Times Cited: 4
Novel Pyrazole-4-Carboxamide Derivatives Containing Oxime Ether Group as Potential SDHIs to Control Rhizoctonia solani
Bo Luo, Yuerui Wu, Xinran Ren, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 17, pp. 9599-9610
Closed Access | Times Cited: 3
Synthesis and anticancer activity of 3-(1-aryl-5-methyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazole-4-carbaldehydes
Bakr F. Abdel-Wahab, Benson M. Kariuki, Hanan A. Mohamed, et al.
Journal of Molecular Structure (2023) Vol. 1294, pp. 136528-136528
Open Access | Times Cited: 8
A novel class of pyrazole analogues as aurora kinase A inhibitor: design, synthesis, and anticancer evaluation
Digambar Yevale, Nishith Teraiya, Twinkle Lalwani, et al.
Bioorganic Chemistry (2023) Vol. 141, pp. 106901-106901
Closed Access | Times Cited: 8
Design, synthesis, and anticancer evaluation of alkynylated pyrrole derivatives
Hegeng Wei, Yu Cao, Chungang Zhao, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 2
Closed Access | Times Cited: 2
Experimental and theoretical studies of pyrazole-4-carbaldehyde derivatives by X-ray crystallography, DFT, molecular docking, and molecular dynamics simulation
Fahad Abdulaziz, Asif Jamal, Md. Serajul Haque Faizi, et al.
Journal of Molecular Structure (2024) Vol. 1321, pp. 139796-139796
Closed Access | Times Cited: 2
Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets
Alia Mushtaq, Peng Wu, Muhammad Moazzam Naseer
Pharmacology & Therapeutics (2023) Vol. 254, pp. 108579-108579
Closed Access | Times Cited: 6
Synthesis, in vitro α‐Glucosidase Inhibition, DFT Calculations, and Molecular Docking Studies of Some New Substituted 2,5‐Bis(pyrazolyl)‐1,3,4‐oxadiazoles
Faryal Chaudhry, Shawana Abdullah, Mehr un‐Nisa, et al.
ChemistrySelect (2024) Vol. 9, Iss. 9
Closed Access | Times Cited: 1
Organocatalyzed, Three‐Component Construction of Cyanopyrazoles Using Diazoacetonitrile
Anamika Dhami, Anuj Kumar, Kalathingal Nasreen Hisana, et al.
Advanced Synthesis & Catalysis (2024) Vol. 366, Iss. 11, pp. 2551-2556
Closed Access | Times Cited: 1
Structure–Activity Relationship Studies on Highly Functionalized Pyrazole Hydrazones and Amides as Antiproliferative and Antioxidant Agents
Matteo Lusardi, Maria Grazia Signorello, Eleonora Russo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4607-4607
Open Access | Times Cited: 1
Convenient One‐Pot Synthesis and Biological Evaluation of New 3,5‐Dimethyl‐1H‐pyrazole‐1‐carbothiohydrazide Derivatives as Anti‐Tumor Agents
Marwa Fouad, Mahmoud M. Elaasser
ChemistrySelect (2024) Vol. 9, Iss. 11
Closed Access
Development and assessment of novel pyrazole–thiadiazol hybrid derivatives as VEGFR-2 inhibitors: design, synthesis, anticancer activity evaluation, molecular docking, and molecular dynamics simulation
Gresa Halimi, Derya Osmani̇ye, Yusuf Özkay, et al.
Zeitschrift für Naturforschung C (2024) Vol. 79, Iss. 9-10, pp. 291-304
Closed Access
A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo–Pyrazole Treatment in SKMEL-28 Melanoma Cells
Erika Iervasi, Gabriela Coronel Vargas, Tiziana Bachetti, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6760-6760
Open Access
Current scenario of pyrazole hybrids with anti‐breast cancer therapeutic applications
Mengyu Ma
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Closed Access
Design and synthesis of new nicotinamide derivatives generated via Suzuki Miyaura coupling as potential anticancer hits targeting pancreatic cancer cell line MIA PaCa-2
L Vedavi, Abdul Rahman, Pooja S Rajaput, et al.
Journal of Molecular Structure (2024) Vol. 1318, pp. 139244-139244
Closed Access
Multicomponent Synthesis of New Fluorescent Boron Complexes Derived from 3-Hydroxy-1-phenyl-1H-pyrazole-4-carbaldehyde
Viktorija Savickienė, Aurimas Bieliauskas, Sergey Belyakov, et al.
Molecules (2024) Vol. 29, Iss. 14, pp. 3432-3432
Open Access
Design and discovery of carboxamide-based pyrazole conjugates with multifaceted potential against Triple-Negative Breast cancer MDA-MB-231 cells
K. T. Ashitha, S Lakshmi, Anjali Sobha, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 113, pp. 129960-129960
Closed Access
Design, Synthesis, and Biological Evaluation of HDAC Inhibitors Containing Natural Product-Inspired N-Linked 2-Acetylpyrrole Cap
Han Zhang, Qianqian Shen, Hu Zhu, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4653-4653
Open Access
Photocatalytic One-Pot Three-Component Reaction for the Regioselective Synthesis of Bromo-Substituted Pyrazoles
Zhiying Zhang, Yinyin Li, Yatang Wang, et al.
The Journal of Organic Chemistry (2024) Vol. 89, Iss. 22, pp. 16809-16827
Closed Access
Modifications of 4‐Amino‐substituted 5‐Phenyl‐3‐(trifluoromethyl)pyrazoles for the Development of New Analgesics
Evgeny V. Shchegolkov, Anastasia N. Perminova, Natalia A. Malkova, et al.
ChemistrySelect (2023) Vol. 8, Iss. 47
Closed Access | Times Cited: 1
Convenient one-pot synthesis and biological evaluation of novel 3,5-dimethyl-1H-pyrazole-1-carbothiohydrazide derivatives as new anti-tumor agents against both liver carcinoma (HepG2) and lung carcinoma (A549) cell lines
Marwa Fouad, Mahmoud M. Elaasser
(2023)
Open Access | Times Cited: 1
Page 1

Scroll to top